VTVT
vTv Therapeutics Inc
30.60$
-4.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | |
| 1,209.1% | 5,700.2% | 7,215.8% | 13,622.0% | 185.3% | 547.0% | 171.7% | 2.2% | 4.6% | 1,000.0% | 8.8% | – | |
| -1,109.1% | 100.0% | -7,115.8% | -13,522.0% | -85.3% | -447.0% | -71.7% | 100.0% | 100.0% | -1,000.0% | 100.0% | – | |
| 1,209.1% | 5,700.2% | 7,215.8% | 13,622.0% | 185.3% | 547.0% | 171.7% | 332.7% | 612.3% | 151,055.6% | 1,135.3% | – | |
| 756.4% | 1,748.9% | 1,562.5% | 3,894.5% | 74.2% | 308.9% | 113.0% | 308.2% | 604.6% | 132,300.0% | 1,342.3% | – | |
| 1,965.5% | 7,449.1% | 8,778.2% | 17,516.5% | 259.4% | 855.9% | 113.0% | 640.9% | 1,216.9% | 283,355.6% | 2,477.6% | – | |
| -1,865.5% | -7,349.1% | -8,678.2% | -17,416.5% | -159.4% | -755.9% | -184.8% | -540.9% | -1,116.9% | -283,355.6% | -2,377.6% | – | |
| 387.9% | 334.3% | 62.8% | 1,062.5% | 26.5% | 66.1% | 10.8% | 0.3% | 0.7% | 144.4% | 0.0% | – | |
| -2,330.6% | -7,920.4% | -8,730.8% | -18,504.1% | -190.2% | -790.1% | -199.6% | -439.9% | -1,232.6% | -288,511.1% | -2,222.7% | – | |
| 315.2% | -2,718.7% | -6,151.6% | 274.9% | 1.6% | 3.6% | -62.0% | 2.9% | 9.9% | -63,511.1% | 9.8% | – | |
| -2,330.6% | -5,298.3% | -2,579.2% | -5,547.8% | -63.6% | -793.7% | -132.5% | -324.3% | -949.7% | -225,000.0% | -1,815.3% | – | |
| -1,886.9% | -7,252.6% | -8,626.2% | -17,373.9% | -162.0% | -722.6% | -187.3% | -437.3% | -1,227.3% | -287,366.7% | -2,214.0% | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.